Medication info

Sodium Chloride and Dextrose Injection(1-3)

Prescription medicationIntravenous injection
Ingredient · strength
Glucose›37.5g / 1000mLSodium Chloride›2.25g / 1000mL
Manufacturer / importer
Daehan Pharmaceutical Co., Ltd.
Appearance
This medication is a colorless, transparent solution with a slight salty and sweet taste, filled in colorless transparent glass or plastic containers.
Packaging
500mL/pack
Approval status
Active

MFDS item code 197100022 · Notified 1971.09.14 · Insurance code 645100852

Summary

Main use
Correction of fluid and electrolyte deficiencies and energy deficiency
Who receives it
Adults · Children
Adult administration
Usually, 500~1,000mL is administered by intravenous infusion per dose to adults. The infusion rate is 300~500mL per hour (75~120 drops per minute). The dose and infusion rate may be adjusted as appropriate according to age, body weight, and symptoms.
Child administration
For children, administer at a rate of 50~100mL per hour. In particular, do not administer by rapid infusion (100mL or more per hour) to newborns or premature infants.

Ingredients

Manufacturer
Daehan Pharmaceutical Co., Ltd.

Efficacy & effects

Correction of fluid and electrolyte deficiencies and energy deficiency

  • Dehydration
View approved original text

This medication is used to replenish body fluids and electrolytes in cases of dehydration or before and after surgery. It also helps supply energy to the body to aid in recovery.

How it is given

Adult administration

Usually, 500~1,000mL is administered by intravenous infusion per dose to adults. The infusion rate is 300~500mL per hour (75~120 drops per minute). The dose and infusion rate may be adjusted as appropriate according to age, body weight, and symptoms.

Child administration

For children, administer at a rate of 50~100mL per hour. In particular, do not administer by rapid infusion (100mL or more per hour) to newborns or premature infants.

Precautions

This medication contains dextrose, which may increase the consumption of thiamine (vitamin B1) in the body during intravenous administration. Therefore, there is a risk of sudden, potentially fatal thiamine deficiency, so caution is required. This medication should not be administered to patients with excessive fluid status or storage dehydration, or hypokalemia. Care should be taken when administering this medication to patients with renal impairment due to kidney disease, heart failure, hypertonic dehydration, reduced urine output due to obstructive uropathy, diabetes mellitus, or hyperchloremia. Rapid or large volume administration of this medication may cause side effects such as cerebral edema, pulmonary edema, peripheral edema, acidosis, and water intoxication. The risk of water intoxication is particularly higher in neonates and premature infants. Additionally, thrombosis may occur at the intravenous injection site, so caution is necessary. During administration, blood glucose, serum electrolytes, and fluid balance should be regularly monitored to ensure no abnormalities. The safety of this medication during pregnancy has not been completely established, and it should be administered only after careful consideration of the risks to the fetus and therapeutic effects. Administering dextrose-containing solutions during labor may lead to metabolic abnormalities such as hyperglycemia or hypoglycemia in both the mother and fetus, so caution is required. Newborns, especially preterm or low-birth-weight infants, face a high risk of hypoglycemia or hyperglycemia due to difficulty in blood sugar control, so close observation and management are necessary. Care should be taken not to administer rapidly or for prolonged periods in infants and the elderly, and in the elderly, it should be administered more cautiously to prevent circulatory overload in those with heart failure or renal failure. In cases of overdose, diuretics should be used to manage the body's fluid and electrolyte balance. Before administration, the patient's infection status should be checked and the skin and infusion equipment should be thoroughly disinfected. During cold conditions, the medication should be warmed to body temperature before use, and any remaining medication should be discarded immediately after opening. Administration should be done slowly via intravenous infusion to reduce the risk of side effects. Care should be taken to avoid air entering the infusion container, and continuous connections should be made to prevent the risk of air embolism. Finally, this medication should be stored at room temperature, and care should be taken regarding temperature changes during storage.

Side effects

  • Cerebral edema
  • pulmonary edema
  • peripheral edema
  • acidosis
  • water intoxication
  • thrombosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering, and it is best to store it at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the efficacy of the medication.

Appearance and packaging

Appearance

This medication is a colorless, transparent solution with a slight salty and sweet taste, filled in colorless transparent glass or plastic containers.

Package unit

500mL/pack

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.